Share on StockTwits

PharMerica (NYSE:PMC)‘s stock had its “buy” rating restated by KeyCorp in a research note issued on Monday. They currently have a $33.00 price objective on the stock, up from their previous price objective of $31.00. KeyCorp’s price target suggests a potential upside of 10.96% from the company’s current price.

Shares of PharMerica (NYSE:PMC) traded down 0.13% on Monday, hitting $29.70. 89,262 shares of the company’s stock traded hands. PharMerica has a one year low of $11.84 and a one year high of $30.48. The stock has a 50-day moving average of $27.57 and a 200-day moving average of $24.76. The company has a market cap of $890.8 million and a price-to-earnings ratio of 67.44.

PharMerica (NYSE:PMC) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.37 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.33 by $0.04. The company had revenue of $452.20 million for the quarter, compared to the consensus estimate of $417.76 million. During the same quarter last year, the company posted $0.46 earnings per share. PharMerica’s revenue was up 2.8% compared to the same quarter last year. Analysts expect that PharMerica will post $1.49 EPS for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks downgraded shares of PharMerica from an “outperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $31.40 price target on the stock. Finally, analysts at Barclays reiterated an “underweight” rating on shares of PharMerica in a research note on Friday, May 2nd. They now have a $26.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $25.49.

PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.